Baylor College of Medicine is a health sciences university that creates knowledge and applies science and discoveries to further education, healthcare and community service locally and globally. Learn more about our mission, vision and values.
Manuscripts submitted for publication (preprints), peer-reviewed pre-publication articles (postprints), and published articles from the faculty of Baylor College of Medicine are posted here with additional links to supplemental data.
Ranked 20th in the nation, and first in Texas since 2006 for obtaining National Institutes of Health (NIH) funding, Baylor College of Medicine received $687 million in total funding from 2,792 sponsored project awards in fiscal year 2023. Baylor operates more than 90 research and patient-care centers and units. BCM also operates more than 27 Advanced Technology Core Laboratories that provide services for studies in areas like metabolomics, proteomics, pathology, and genomics.
Submissions from 2026
Whole Genome Sequencing Analysis of Over 3500 Individuals Dementia-Free Over 85 Years Old, Gina M Peloso, Dongyu Wang, Sabrina M Abbruzzese, et al.
Transcriptomic Signature-Guided Depletion of Intermediate Alveolar Epithelial Cells Ameliorates Pulmonary Fibrosis in Mice, Fei Peng, Chun-Sun Jiang, Zhen Zheng, et al.
Suicidal Ideation in Spinocerebellar Ataxia, Levi Peppel, Ruo-Yah Lai, Christian Rummey, et al.
Neuronal Subtype Governs Amyloid Structure, Cellular Response, and Cognitive Outcome in Genetically Targeted App Mouse Models, Gabriella A Perez, Zoe Lai, George A Edwards Iii, et al.
Utilizing a Culture System for Horizontal Cells To Study Neural Circuit Assembly in the Developing Mouse Retina, Ross M Perez, Yong H Park, Ajeet Singh, et al.
Using Lotilaner Ophthalmic Solution, 0.25% to Treat Demodex Blepharitis in Patients Who Were Initially Misdiagnosed: A Case Series, Laura M Periman, Richard Lindstrom, Paul Karpecki, et al.
Matching-Adjusted Indirect Comparison of Acoltremon Ophthalmic Solution 0.003% and Cyclosporine 0.05% Ophthalmic Emulsion for Increased Tear Production in Patients With Dry Eye Disease, Stephen Pflugfelder, Tony Okoro, Margaret Ainslie-Garcia, et al.
Tulane Virus Protease as a Structural Surrogate for Inhibitor Screening of Human Norovirus Proteases, Son Pham, Nikhil Sharma, Banumathi Sankaran, et al.
Variability in the Orthopaedic Residency Trainee Trauma Surgical Experience, Todd Phillips, Benjamin Fiedler, Joshua T Morrow, et al.
Non-Invasive Intracranial Pressure Estimation in the Intensive Care Unit: Narrative Review of Methods and Clinical Applications, Edoardo Picetti, Daniele Guerino Biasucci, Elisa Gouvea Bogossian, et al.
Integrating a Project-Based Learning Methodology into a Department-Wide Quality Improvement Curriculum: A Nine-Year Experience in Pediatric Subspecialty Training, Venessa Lynn Pinto, Danny Castro, Constance M Wiemann, et al.
Survodutide for the Treatment of Obesity: Baseline Characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial, Elke Platz, Lee M Kaplan, Carel W le Roux, et al.
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines, Elke Platz, Alexander Peikert, Biykem Bozkurt, et al.
Unraveling Posttranslational Modification Complexity: Advances in Quantitative Histone Proteoform Mass Spectrometry, Karl F Poncha, Alyssa T Paparella, and Nicolas L Young
Functional Genomics Studies of Psychiatric Disorders in Individuals of Latin American Populations: A Scoping Review, Luz M Porras, Isabelle Rodríguez-Lausell, Gabriel Iglesias-Maldonado, et al.
Impact of Long-Term Nitrogen Scavenger Therapy on Clinical Outcome in Individuals With Urea Cycle Disorders, Roland Posset, Friederike Epp, Sven F Garbade, et al.
Detection, Persistence, and Rising Prevalence of Oncogenic Viruses Revealed by Wastewater Metagenomics, Harihara Prakash, Ryan K Perez, Matt Ross, et al.
Development of Novel Plasma Proteomic Biomarkers for Cancer-Associated Thrombosis in an Advanced Cancer Cohort, Preeti, Mrinal Ranjan, Dang Pham, et al.
When Probiotics Guidelines Differ: A Practical Guide for Clinicians and Researchers, Geoffrey A Preidis, Hania Szajewska, Marla Cunningham, et al.
Putting the L in ELSI: Legal Methods for Bioethics Research, Anya E R Prince, Benjamin Berkman, Donald Ford, et al.
Combination Therapy with 308-nm Excimer Laser, Compound Glycyrrhizin, and Tacrolimus for Pediatric Facial and Cervical Vitiligo, Yingying Qian, Yafen Wu, Wei Li, et al.
Purpuric Pityriasis Rosea in a 7-Year-Old Girl: A Rare Variant With Generalized Involvement, Ying-Ying Qian, Ya-Fen Wu, Ting Zhang, et al.
Corrigendum to “Characterizing the Metabolites of the Tyrosine-Kinase Inhibitor Pexidartinib in Mouse Feces, Urine, Plasma, and Liver” [J. Pharm. Biomed. Anal. 265 (2025) 117034], Xuan Qin, Si Chen, John M Hakenjos, et al.
Histone Deacetylase Enzyme Activity Is Not the Universal Anticancer Target of HDAC Inhibitors, Chaitra Rai, Hang Ruan, Xue Li, et al.
Dhodh Links Mitochondrial Bioenergetics, One-Carbon Metabolism, and DNA Repair To Sustain Aggressive Prostate Adenocarcinoma, Saiswaroop Rajaratnam, Danthasinghe Waduge Badrajee Piyarathna, Ranjit K Mehta, et al.